title: The pro-coagulant fibrinogenolytic serine protease isoenzymes purified from Daboia russelii russelii venom coagulate the blood through factor V activation: role of glycosylation on enzymatic activity.
abstract: Proteases from Russell's viper venom (RVV) induce a variety of toxic effects in victim. Therefore, four new RVV protease isoenzymes of molecular mass 32901.044 Da, 333631.179 Da, 333571.472 Da, and 34594.776 Da, were characterized in this study. The first 10 N-terminal residues of these serine protease isoenzymes showed significant sequence homology with N-terminal sequences of snake venom thrombin-like and factor V-activating serine proteases, which was reconfirmed by peptide mass fingerprinting analysis. These proteases were found to be different from previously reported factor V activators isolated from snake venoms. These proteases showed significantly different fibrinogenolytic, BAEE-esterase and plasma clotting activities but no fibrinolytic, TAME-esterase or amidolytic activity against the chromogenic substrate for trypsin, thrombin, plasmin and factor Xa. Their Km and Vmax values towards fibrinogen were determined in the range of 6.6 to 10.5 µM and 111.0 to 125.5 units/mg protein, respectively. On the basis of fibrinogen degradation pattern, they may be classified as A/B serine proteases isolated from snake venom. These proteases contain ∼ 42% to 44% of N-linked carbohydrates by mass whereas partially deglycosylated enzymes showed significantly less catalytic activity as compared to native enzymes. In vitro these protease isoenzymes induce blood coagulation through factor V activation, whereas in vivo they provoke dose-dependent defibrinogenation and anticoagulant activity in the mouse model. At a dose of 5 mg/kg, none of these protease isoenzymes were found to be lethal in mice or house geckos, suggesting therapeutic application of these anticoagulant peptides for the prevention of thrombosis.
authors: Department of Molecular Biology and Biotechnology, Tezpur University, Tezpur, Assam, India ; School of Biological Sciences, University of Northern Colorado, Greeley, Colorado, United States of America.
authors: Ashis K
authors: AK
authors: Mukherjee
mesh_terms: D000577:Amides / Q000378:metabolism; D000595:Amino Acid Sequence; D000818:Animals; D001777:Blood Coagulation / Q000187:drug effects*; D002265:Carboxylic Ester Hydrolases / Q000378:metabolism; D002417:Cattle; D002863:Chromogenic Compounds / Q000378:metabolism; D003029:Coagulants / Q000494:pharmacology*; D004591:Electrophoresis, Polyacrylamide Gel; D015943:Factor Va / Q000378:metabolism*; D005340:Fibrinogen / Q000378:metabolism*; D006031:Glycosylation; D007527:Isoenzymes / Q000737:chemistry / Q000302:isolation & purification / Q000378:metabolism; D051379:Mice; D023421:Models, Animal; D008969:Molecular Sequence Data; D017840:Daboia / Q000378:metabolism*; D016415:Sequence Alignment; D057057:Serine Proteases / Q000737:chemistry / Q000302:isolation & purification* / Q000378:metabolism; D014757:Viper Venoms / Q000201:enzymology*
chemical_list: D000577:Amides; D002863:Chromogenic Compounds; D003029:Coagulants; D007527:Isoenzymes; D014757:Viper Venoms; D015943:Factor Va; D005340:Fibrinogen; D002265:Carboxylic Ester Hydrolases; C019763:benzoylarginine ethyl esterase; D057057:Serine Proteases